PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Am Chem Soc. Author manuscript; available in PMC Nov 28, 2008.
Published in final edited form as:
PMCID: PMC2574519
NIHMSID: NIHMS62888

Photo-leucine incorporation reveals the target of a cyclodepsipeptide inhibitor of cotranslational translocation

Abstract

An external file that holds a picture, illustration, etc.
Object name is nihms62888u1.jpg

Photoaffinity labeling is a powerful tool to identify protein targets of biologically active small molecules, yet is often limited by the size, chemical properties, and availability of photo-reactive groups. We report an improved synthesis of photo-leucine, a diazirine-based photo-reactive analog of leucine, and demonstrate its incorporation into a cyclodepsipeptide inhibitor of cotranslational translocation. Photoaffinity labeling in a crude membrane fraction, followed by “click chemistry” with a rhodamine-azide reporter, enabled the identification of Sec61α, the structural core of the Sec61 translocation channel, as the inhibitor’s target.

Photoaffinity labeling is a powerful tool to identify protein targets of biologically active small molecules and probe the structure of ligand binding sites, especially in the case of integral membrane proteins.1 A difficulty with photoaffinity labeling is that the small molecule must retain biological activity after derivatization with a photo-reactive group such as benzophenone2 or 3-trifluoromethyl-3-phenyl diazirine.3 While these substituents are effective photo-crosslinkers and have been incorporated into small molecules,4 peptides,5 and proteins,6 their large size can potentially interfere with small molecule/protein interactions. The amino acid isosteres, “photo-leucine” and “photo-methionine”, have smaller alkyl diazirine side chains and were recently used to probe protein-protein interactions after random biosynthetic incorporation in cells7 or via site-specific native protein ligation.8 By contrast, the potential for incorporating these novel photo-reactive amino acids into natural product scaffolds has not been explored. In this communication we report: (1) an improved synthesis of photo-leucine, (2) incorporation of photo-leucine and an alkyne “click chemistry” tag into a cyclodepsipeptide inhibitor of protein secretion, and (3) identification of the inhibitor’s target by photoaffinity labeling.

An external file that holds a picture, illustration, etc.
Object name is nihms62888u2.jpg

HUN-7293 (1) is a fungal cyclodepsipeptide that was first identified as an inhibitor of vascular cell adhesion molecule (VCAM) expression.9 Recently, we10 and others11 discovered that related cyclodepsipeptides potently block the cotranslational translocation of VCAM and a subset of other proteins into the endoplasmic reticulum (ER), an early step in the biogenesis of secretory and membrane proteins. Biochemical experiments revealed that these compounds act at the ER membrane to perturb interactions between nascent ribosome-associated VCAM chains and the translocation channel. A heterotrimeric membrane protein, the Sec61 complex, forms the structural core of this channel12 and thus emerged as a potential direct target of 1.

To identify the target, we designed photoaffinity probe 2, in which photo-leucine replaces leucine at position 4 of 1. We substituted N-methyl-phenylalanine at position 5, previously shown to have a negligible effect on potency.13 A propargyl substituent was installed at position 1 to enable Cu(I)-catalyzed conjugation of a rhodamine-azide reporter14 (click chemistry) after photo-crosslinking under native conditions (Figure 1). These conservative modifications were aimed at preserving the biological potency of 1 while providing the necessary functionality for target identification.

Figure 1
Photoaffinity labeling strategy to identify the target of 2.

Synthesis of 2 required Boc-(S)-photo-leucine (6), which we prepared via ozonolysis of commercially available 4,15 followed by formation of the diazirine by the method of Church and Weiss (Scheme 1).16 Boc-(S)-photo-leucine was efficiently coupled to peptides (EDCI-HOAt) or deprotected (4 N HC1) to give the free amino acid in quantitative yield. This route is a significant improvement over the original six-step synthesis of (S)-photo-leucine, which proceeded in low yield and required enzymatic resolution of a racemic intermediate.7 Synthesis of 2 followed the solution-phase route developed by Boger and coworkers13 with slight modifications. The diazirine side chain was stable to ambient light and the acidic and basic conditions used to prepare 2. We also synthesized 3 as a photo-stable control compound. Both 2 and 3 were equipotent to the natural product 1 at inhibiting VCAM expression in transfected cells (EC50~25 nM, Figure SI).

Scheme 1
Synthesis of Boc-(S)-photo-leucine

We incubated a crude ER microsome fraction with 500 nM 2 and irradiated the mixture with ~350 nm light for 1 min. Proteins were denatured in 1% sodium dodecylsulfate (SDS) and subjected to standard click chemistry conditions using a rhodamine-azide reporter (see Supporting Information). Following electrophoresis, in-gel fluorescent scanning revealed a major rhodamine-labeled protein with an apparent molecular weight of ~50 kDa (Figure 2A, lane 1). Labeling of this protein required both UV light (lane 5) and 2 (lane 6), and was competed by excess 3 (lanes 2–4). Weak labeling of two additional proteins (~60 kDa and ~40 kDa) was not competed by excess 3 and is likely non-specific. Background labeling by the rhodamine-azide, independent of UV light or 2, was also observed (lanes 5 and 6).

Figure 2
(A) Photo-crosslinking of 2 in the presence of ER microsomes, followed by click chemistry with a rhodamine-azide reporter. An asterisk marks the major photo-crosslinked protein. (B) Sec61α antibody or rabbit serum (control) was added to photolysis/click ...

The major crosslinked protein migrated on SDS gels with the same relative mobility as Sec61α, the largest subunit of the Sec61 complex (Figure S2). Consistent with Sec61α as the primary target of 2, the ~50 kDa rhodamine-labeled protein was immuno-precipitated directly from the click reaction mixture with an antibody raised against Sec61α, but not with a control antibody (Figure 2B).

To independently confirm that Sec61α is the photo-crosslinked protein, we prepared proteoliposomes reconstituted from either a detergent extract of ER microsomes, a Sec61-depleted extract, or a depleted extract replenished with purified Sec61 complex.17 Depletion of the intact Sec61 complex from the detergent extract using antibodies against Sec61β18 was ~90% efficient (as judged by immunoblotting for the α and β subunits), whereas other ER proteins were not affected (Figure S3). Compared to proteoliposomes derived from control extracts (Figure 2C, lane 3), photo-crosslinking of 2 to the ~50 kDa protein was significantly diminished in Sec61-depleted proteoliposomes (lane 1) and was restored after adding back purified Sec61 complex (lane 2). We conclude that Sec61α, thought to form the channel through which all proteins transit as they enter the secretory pathway, is the primary target of 2 in the ER.

Photo-crosslinking of 2 to Sec61α is remarkably selective given the proteomic complexity of the ER, which contains hundreds of membrane and luminal proteins;19 Sec61α is a relatively minor constituent (~0.7% of total ER protein).20 We attribute this high selectivity to two factors. First, due to its similar size, shape, and hydrophobicity, photo-leucine likely forms intimate contacts with Sec61α in a manner similar to the leucine side chain of 1. Second, the short lifetime (nanoseconds)21 of the carbene derived from 2 (Figure 1) ensures that molecules not bound to Sec61α are rapidly quenched by intramolecular rearrangement, solvent, or membrane lipids. Despite the short lifetime, the photo-crosslinking yield of 2 to Sec61α was estimated to be ~23% (Figure S4). Thus, depending on the specific application, alkyl diazirines may offer advantages over the widely used benzophenone crosslinker. The modular cyclodepsipeptide scaffold of 1 should facilitate installation of a diazirine at multiple positions. High-resolution mapping of the crosslinking site(s) by mass spectrometry will likely shed light on the mechanism by which these compounds selectively inhibit cotranslational translocation.

Supplementary Material

1

Supporting Information Available:

Detailed experimental section, synthesis and spectral characterization of new compounds.

Acknowledgments

This work was supported by the NIH (GM81644), the intramural research program of the NICHD, and the Scleroderma Research Foundation.

References

1. For reviews, see (a) Sadakane Y, Hatanaka Y Anal Sci. 2006;22:209–218. [PubMed]
(b) Kotzyba-Hibert F, Kapfer I, Goeldner M Angew Chem Int Ed Engl. 1995;34:1296–1312.
2. Dormán G, Prestwich GD. Biochemistry. 1994;33:5661–5673. [PubMed]
3. Brunner J. Amu Rev Biochem. 1993;62:483–514. [PubMed]
4. For recent examples, see (a) Kotake Y, Sagane K, Owa T, Mimori-Kiyosue Y, Shimizu H, Uesugi M, Ishihama Y, Iwata W, Mizui Y Nat Chem Biol. 2007;22 Advanced online publication.
(b) Fuwa H, Takahashi Y, Konno Y, Watanabe N, Miyashita H, Sasaki M, Natsugari H, Kan T, Fukuyama T, Tomita T, Iwatsubo T ACS Chem Biol. 2007;2:408–418. [PubMed]
5. Kauer JC, Erickson-Viitanen S, Wolfe HR, Jr, DeGrado WF. J Biol Chem. 1986;261:10695–10700. [PubMed]
6. (a) Chin JW, Martin AB, King DS, Wang L, Shultz PG. Proc Natl Acad Set. 2002;99:11020–11024. [PubMed] (b) High S, Martoglio B, Görlich D, Andersen SSL, Ashford AJ, Giner A, Hartmann E, Prehn S, Rapoport TA, Dobberstein B, Brunner J. J Biol Chem. 1993;268:26745–26751. [PubMed]
7. Suchanek M, Radzikowska A, Thiele C. Nat Meth. 2005;2:261–268. [PubMed]
8. Vila-Perelló M, Pratt MR, Tulin F, Muir TW. J Am Chem Soc. 2007;129:8068–8069. [PMC free article] [PubMed]
9. (a) Foster CA, Dreyfuss M, Mandak B, Meingassner JG, Naegeli HU, Nussbaumer A, Oberer L, Scheel G, Swoboda EM. J Dermatol. 1994;21:847–854. [PubMed] (b) Boger DL, Keim H, Oberhauser B, Schreiner EP, Foster CA. J Am Chem Soc. 1999;121:6197–6205.
10. Garrison JL, Kunkel EJ, Hegde RS, Taunton J. Nature. 2005;436:285–289. [PubMed]
11. Besemer J, Harant H, Wang S, Oberhauser B, Marquardt K, Foster CA, Schreiner EP, de Vries JE, Dascher-Nadel C, Lindley IL. Nature. 2005;436:290–293. [PubMed]
12. Osborne AR, Rapoport TA, van den Berg B. Annu Rev Cell Dev Biol. 2005;21:529–550. [PubMed]
13. Chen Y, Bilban M, Foster CA, Boger DL. J Am Chem Soc. 2002;124:5431–5440. [PubMed]
14. (a) Speers AE, Cravatt BF. Chem Biol. 2004;11:535–546. [PubMed] (b) Cohen MS, Hadjivassiliou H, Taunton J. Nat Chem Biol. 2007;3:156–160. [PubMed]
15. Cornish VW, Hahn KM, Shultz PG. J Am Chem Soc. 1996;118:8150–8151.
16. Church RFR, Weiss MJ. J Org Chem. 1970;35:2465–2471.
17. Görlich D, Rapoport TA. Cell. 1993;75:615–630. [PubMed]
18. Fons RD, Bogert BA, Hegde RS. J Cell Biol. 2003;160:529–539. [PMC free article] [PubMed]
19. Gilchrist A, Au CE, Hiding J, Bell AW, Fernandez-Rodriguez J, Lesimple S, Nagaya H, Roy L, Gosline SJC, Hallett M, Paiement J, Kearney RE, Nilsson T, Bergeron JJM. Cell. 2006;127:1265–1281. [PubMed]
20. Guth S, Völzing C, Müller A, Jung M, Zimmermann R. Eur J Biochem. 2004;271:3200–3207. [PubMed]
21. Ford F, Yuzawa T, Platz MS, Matzinger S, Fülscher M. J Am Chem Soc. 1998;120:4430–4438.